Diego A. Gianolio

1.4k total citations · 1 hit paper
32 papers, 889 citations indexed

About

Diego A. Gianolio is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Diego A. Gianolio has authored 32 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Hematology and 9 papers in Oncology. Recurrent topics in Diego A. Gianolio's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Diego A. Gianolio is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Diego A. Gianolio collaborates with scholars based in United States, France and Germany. Diego A. Gianolio's co-authors include Larry W. McLaughlin, Christian Récher, Jianxiang Wang, Rodrigo T. Calado, Michael Heuser, Jianan Hui, Hartmut Döhner, Scott R. Daigle, Su‐Peng Yeh and Andre C. Schuh and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Diego A. Gianolio

30 papers receiving 858 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia

2022 295 citations Pau Montesinos, Christian Récher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego A. Gianolio United States	14	487	268	254	211	104	32	889
Benno Rattel Germany	17	452 0.9×	804 3.0×	257 1.0×	469 2.2×	44 0.4×	36	1.3k
Robert S. Greenfield United States	17	480 1.0×	334 1.2×	90 0.4×	388 1.8×	169 1.6×	43	1.3k
Anlai Wang United States	12	330 0.7×	228 0.9×	312 1.2×	34 0.2×	105 1.0×	40	958
Marilyn C. Darkes United States	14	415 0.9×	309 1.2×	73 0.3×	189 0.9×	76 0.7×	18	1.0k
Leopold Sellner Germany	24	678 1.4×	806 3.0×	139 0.5×	70 0.3×	250 2.4×	57	1.6k
Micah John Luderer United States	12	222 0.5×	160 0.6×	189 0.7×	136 0.6×	38 0.4×	15	592
Cheng Cheng Zhang United States	12	334 0.7×	199 0.7×	385 1.5×	64 0.3×	27 0.3×	14	978
Paul M. Armistead United States	21	729 1.5×	396 1.5×	315 1.2×	55 0.3×	17 0.2×	71	1.6k
Fangyuan Chen China	18	444 0.9×	149 0.6×	93 0.4×	69 0.3×	160 1.5×	72	1.2k
Janis Upeslacis United States	10	483 1.0×	595 2.2×	148 0.6×	509 2.4×	275 2.6×	11	1.2k

Countries citing papers authored by Diego A. Gianolio

Since Specialization

Citations

This map shows the geographic impact of Diego A. Gianolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego A. Gianolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego A. Gianolio more than expected).

Fields of papers citing papers by Diego A. Gianolio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego A. Gianolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego A. Gianolio. The network helps show where Diego A. Gianolio may publish in the future.

Co-authorship network of co-authors of Diego A. Gianolio

This figure shows the co-authorship network connecting the top 25 collaborators of Diego A. Gianolio. A scholar is included among the top collaborators of Diego A. Gianolio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego A. Gianolio. Diego A. Gianolio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tap, William D., Gregory M. Coté, Howard A. Burris, et al.. (2025). Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma. Clinical Cancer Research. 31(11). 2108–2114. 1 indexed citations

Montesinos, Pau, Dylan M. Marchione, Christian Récher, et al.. (2025). Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1 -mutated AML. Blood Advances. 9(20). 5177–5189. 3 indexed citations

Döhner, Hartmut, Pau Montesinos, Ewa Zarzycka, et al.. (2023). P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE. HemaSphere. 7(S3). e83152da–e83152da.

Döhner, Hartmut, Dylan M. Marchione, Sung Choe, et al.. (2022). Molecular Characterization of Clinical Response and Relapse in Patients with IDH1m ND-AML Treated with Ivo+AZA in the AGILE Study. Blood. 140(Supplement 1). 539–542. 3 indexed citations

Botton, Stéphane de, Sung Choe, Dylan M. Marchione, et al.. (2022). Molecular characterization of clinical response in patients with newly diagnosed acute myeloid leukemia treated with ivosidenib + azacitidine compared to placebo + azacitidine.. Journal of Clinical Oncology. 40(16_suppl). 7019–7019. 1 indexed citations

Montesinos, Pau, Christian Récher, Susana Vives, et al.. (2021). AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Blood. 138(Supplement 1). 697–697. 7 indexed citations

Gjyrezi, Ada, Fang Xie, Olga Voznesensky, et al.. (2020). Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. Journal of Clinical Investigation. 130(6). 3287–3298. 38 indexed citations

Chen, Qing, Diego A. Gianolio, James E. Stefano, et al.. (2019). Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody–drug conjugation. Organic & Biomolecular Chemistry. 17(35). 8115–8124. 14 indexed citations

Chen, Qing, Diego A. Gianolio, James E. Stefano, et al.. (2018). Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High‐Drug‐Load Antibody–Drug Conjugates. ChemMedChem. 13(8). 790–794. 11 indexed citations

10.

Durán, George E., Volker Derdau, Dietmar Weitz, et al.. (2018). Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein. Cancer Chemotherapy and Pharmacology. 81(6). 1095–1103. 35 indexed citations

11.

Rouleau, Cécile, Diego A. Gianolio, Robert Smale, et al.. (2015). Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies. Molecular Cancer Therapeutics. 14(9). 2081–2089. 34 indexed citations

12.

Zhou, Qun, James E. Stefano, Josephine Kyazike, et al.. (2014). Site-Specific Antibody–Drug Conjugation through Glycoengineering. Bioconjugate Chemistry. 25(3). 510–520. 177 indexed citations

13.

Stefano, James E., et al.. (2013). Micro- and Mid-Scale Maleimide-Based Conjugation of Cytotoxic Drugs to Antibody Hinge Region Thiols for Tumor Targeting. Methods in molecular biology. 1045. 145–171. 9 indexed citations

14.

Gianolio, Diego A., Cécile Rouleau, William E. Bauta, et al.. (2012). Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates. Cancer Chemotherapy and Pharmacology. 70(3). 439–449. 28 indexed citations

15.

Rouleau, Cécile, Robert Smale, Diego A. Gianolio, et al.. (2009). Abstract C80: Characterizing models for personalized medicine: Endosialin in sarcoma from cultured cells to mice to humans. Molecular Cancer Therapeutics. 8(12_Supplement). C80–C80. 1 indexed citations

16.

Gianolio, Diego A., Luis Z. Avila, Hollace MacGregor, et al.. (2005). Synthesis and Evaluation of Hydrolyzable Hyaluronan-Tethered Bupivacaine Delivery Systems. Bioconjugate Chemistry. 16(6). 1512–1518. 17 indexed citations

17.

Gianolio, Diego A.. (2000). Tethered naphthalene diimide-based intercalators for DNA triplex stabilization. Nucleic Acids Research. 28(10). 2128–2134. 26 indexed citations

18.

Vicic, David A., Duncan T. Odom, Megan E. Núñez, et al.. (2000). Oxidative Repair of a Thymine Dimer in DNA from a Distance by a Covalently Linked Organic Intercalator. Journal of the American Chemical Society. 122(36). 8603–8611. 48 indexed citations

19.

Núñez, Megan E., et al.. (2000). Long-Range Guanine Oxidation in DNA Restriction Fragments by a Triplex-Directed Naphthalene Diimide Intercalator. Biochemistry. 39(20). 6190–6199. 49 indexed citations

20.

Gianolio, Diego A. & Larry W. McLaughlin. (1999). Synthesis and Triplex Forming Properties of Pyrimidine Derivative Containing Extended Functionality. Nucleosides and Nucleotides. 18(8). 1751–1769. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact